BMN 165-304: An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/day Dose) in Adults with Phenylketonuria

Project: Research project

Project Details

StatusActive
Effective start/end date8/31/18 → 8/30/50

Funding

  • BioMarin Pharmaceutical Inc.